Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded ...
A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback